Organization · Venture Capital
RA Capital Management
RA Capital Management is a multi-stage investment manager based in Boston, Massachusetts, focusing on evidence-based investing in healthcare and life science companies. They provide seed funding to startups and lead financing rounds for established firms.
Overview
What RA Capital Management does
What RA Capital Management is
RA Capital Management is a multi-stage investment manager based in Boston, Massachusetts, focusing on evidence-based investing in healthcare and life science companies. They provide seed funding to startups and lead financing rounds for established firms.
How it participates in the startup ecosystem
The current public profile supports funder and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2004
- Approximate age
- About 22 years
- Structured capabilities
- Funder · Publisher
- Last reviewed
- March 16, 2026
Official channels
Find RA Capital Management elsewhere
Open the official website or a supported primary organization account.
Capability profile
RA Capital Management as a funder
Investment thesis
Evidence-based investing in multi-stage healthcare and life sciences companies developing drugs, devices, diagnostics, and research tools
Focus narrative
Healthcare and life sciences: drug discovery, oncology, infectious diseases, autoimmune, gene therapies, medical devices. Also Planetary Health Fund ($120M) for critical minerals, energy, manufacturing.
Value beyond capital
TechAtlas proprietary research platform. Raven incubator for biotech startups. Multi-stage capital from seed through growth. Board-level strategic guidance.
Terms and economics
- Typical check
- $500,000–$75,000,000
- Sweet spot
- $5,000,000
Focus and fit
- Stages
- Seed · Series A · Series B · Series C · Series D · Growth Equity
- Sectors
- Biotech · Drug Discovery · Diagnostics · Genomics · Synthetic Biology · Healthcare · Digital Health · Climate · Energy · Industrial
- Regions
- Global · North America · United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 543
- Investments in the last 12 months
- 12
- Last recorded investment
- June 25, 2025
- Recorded notable exits
- Akouos, Nkarta, PMV Pharma, Vaxcyte, and Aliada Therapeutics
Portfolio context
543 companies with 128+ exits via IPO or acquisition. Portfolio includes Vaxcyte, Ascendis Pharma, Cidara Therapeutics. TechAtlas research division maps competitive landscapes.
Capability profile
RA Capital Management as a publisher
Editorial focus
RA Capital Management is dedicated to evidence-based investing in healthcare and life sciences, supporting companies from seed stage to IPO. Their investment strategy covers a wide range of therapeutic areas and stages of development, with a commitment to innovative solutions in drug development, medical devices, diagnostics, and research tools.
Audience value
RA Capital provides funding and strategic support to healthcare and life science companies, helping them navigate the path from discovery to commercialization.
Format and cadence
- Content formats
- blog
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Investors
- Regions
- North AmericaUnited States
Flagship work and coverage
Flagship properties
RA Capital operates TechAtlas, a research division that analyzes scientific and clinical data to inform investment decisions and support portfolio companies.
Common questions
What to know about RA Capital Management
Upseed classifies RA Capital Management under the Venture Capital organization type. Its current public profile includes funder and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 16, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.